SBIR/STTR Proposal Writing & Grant Preparation Workshop

Jul 10, 2014 7:30 AM - 4:30 PM
Source: VGTI Florida®
Registration Closed

SBIR/STTR Proposal Writing & Grant Preparation Workshop

Registration is closed, please contact Rebecca Reiger to check for availability due to cancellations.

Event Date
July 10, 2014

Have an exciting technology that needs proof of concept funding to move it forward? Need help with preparing and applying for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants?

Join your entrepreneurial colleagues for a full day designed to increase the likelihood of a successful grant submission.

SBIR/STTR Proposal Writing & Grant Preparation Workshop
Date: Thursday, July 10, 2014
Presented by: Greenwood Consulting Group
Hosted by: Vaccine & Gene Therapy Institute of Florida (VGTI Florida®) with support from the Florida Institute for Commercialization of Public Research

What:

NIH/DHS/DoD-focused SBIR Phase I Workshop
When: Thursday, July 10, 2014, 7:30am to 4:30pm
Where: VGTI Florida, Port St. Lucie, Florida
Cost: $25.00

Hotel:
Homewood Suites by Hilton Port St. Lucie-Tradition
10301 SW Innovation Way, Port St Lucie, FL 34987
(772) 345-5300
View Website (Click Here)

Contact: Rebecca Rieger
Marketing & Communications Manager
(772) 345-5697
rrieger@vgtifl.org

Space Is Limited - Register Today!

About Greenwood Consulting Group
Jim Greenwood and his wife, Gail, have been involved in the SBIR program since its inception in 1983. The Greenwoods have taught SBIR/STTR workshops in 48 states plus Puerto Rico and Washington D.C., offering training through local and regional economic development groups, universities, Federal laboratories, SBDCs and MEPs. The Greenwoods also have taught at many of the National SBIR Conferences in the past decade, including the most recent national conferences in Oklahoma City, Reno, New Orleans, Portland and Washington DC. They are recipients of the coveted Tibbetts Award, based on their contributions to SBIR/STTR outreach and education efforts, and were recognized by the Small Business Technology Council as “Champions for Small Business” for their outreach efforts during the latest SBIR/STTR programs reauthorization effort.

In addition to offering SBIR/STTR training, the Greenwoods provide applicants with critiques of draft proposals before they are finalized and submitted for funding. They have performed over 650 such reviews over the past decade, and have always been able to offer suggestions that made the proposals stronger contenders for SBIR/STTR funding.

Jim Greenwood serves as a commercialization reviewer for the SBIR and STTR programs at the National Science Foundation (NSF), reviewing both Phase 1 and 2 proposals, as well as proposals for NSF’s supplemental programs such as Phase 1b and Phase 2b. The Greenwoods also have served on the US Army’s review panel that makes Quality Awards for the Army SBIR/STTR projects with the greatest commercialization potential.

In addition to the Greenwoods’ expertise in SBIR/STTR, they are recognized experts in small business incubators, and have completed over 80 incubator consulting projects throughout the US and Canada.

About VGTI Florida

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®) is a non-profit biomedical research institute dedicated to understanding the roles of our immune system and our genes in disease, as well as the development of innovative treatments.  We are in an expansion phase recruiting leading scientists from around the globe to join VGTI Florida where they can work side-by-side targeting infectious disease, cancer, and the impact of an aging immune system.
 
VGTI Florida's mission of "Translating Research Into Health®" directs our focus to the development of new vaccines and immunotherapies to boost the immune response to infectious diseases and cancer.
 
Of particular interest is understanding differences of the immune response in the elderly resulting in decreased immunity to infectious pathogens, even when vaccinated, and in the appearance of cancer in advanced age.
 
Through a better understanding of how an individual's genetic makeup and immune response contribute to disease we are discovering how to make our immune systems stronger and more protective against viruses and cancer.  VGTI Florida is paving the way for discoveries that will improve the quality of individual treatment outcomes for patients and human health around the globe.
 
About Florida Institute for Commercialization of Public Research
The Institute is a non-profit organization that supports new company creation based on publicly-funded research. Leveraging a $2B research base, the Institute works collaboratively with technology licensing officers across the state to create new companies and jobs in industries that are driving the global economy. 
 
The Institute’s proven, two-pronged approach includes both company building and company funding programs, ensuring that the most promising start-ups receive the support and capital they need in order to grow. With funding from the State of Florida through the Department of Economic Opportunity, and through the generosity of mentors, advisors and donors, the Institute connects the dots between research, discovery and commercialization to build companies that are solving some of today’s toughest challenges.

 

Event Information

rrieger@vgtifl.org
(772) 345-5697
Categories: Events